Bio-Gate AG (FRA:BIG)
Germany · Delayed Price · Currency is EUR 2.875
+0.020 (0.70%)
At close: Aug 5, 2026
Bio-Gate AG Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.7 | 0.3 | 1.33 | 1.61 | 1.97 |
Cash & Short-Term Investments | 0.7 | 0.3 | 1.33 | 1.61 | 1.97 |
Cash Growth | 137.65% | -77.64% | -17.67% | -18.03% | 368.91% |
Receivables | 0.47 | 0.2 | 0.34 | 0.56 | 0.59 |
Inventory | 0.99 | 1.6 | 1.3 | 1.89 | 0.98 |
Other Current Assets | 0.59 | 0.1 | 0.38 | 0.13 | 0.05 |
Total Current Assets | 2.75 | 2.19 | 3.35 | 4.19 | 3.59 |
Property, Plant & Equipment | 0.63 | 0.69 | 0.74 | 0.76 | 0.45 |
Other Intangible Assets | 1.23 | 1 | 1.15 | 1.22 | 1.16 |
Other Long-Term Assets | 0.04 | 0.06 | 0.02 | 0.04 | 0.01 |
Total Assets | 4.66 | 3.95 | 5.26 | 6.22 | 5.21 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.6 | 0.6 | 0.54 | 0.69 | 0.36 |
Accrued Expenses | 0.27 | 0.3 | 0.26 | 0.27 | 0.22 |
Short-Term Debt | 0.44 | 0.43 | 0.42 | 0.42 | 0.41 |
Current Portion of Long-Term Debt | - | - | - | - | 0.05 |
Current Portion of Leases | 0.05 | - | - | - | - |
Current Income Taxes Payable | 0.07 | 0.08 | 0.16 | 0.04 | 0.07 |
Current Unearned Revenue | 0.01 | 0.02 | 0.01 | 0.07 | 0.06 |
Other Current Liabilities | 0.04 | 0.03 | 0.23 | 0.29 | 0.24 |
Total Current Liabilities | 1.48 | 1.46 | 1.62 | 1.78 | 1.41 |
Long-Term Debt | 0.05 | - | - | - | - |
Long-Term Leases | 0.32 | - | - | - | - |
Other Long-Term Liabilities | 1.22 | 0.69 | 0.19 | 0.18 | 0.03 |
Total Liabilities | 3.06 | 2.16 | 1.81 | 1.97 | 1.44 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 10.19 | 9.24 | 9.24 | 8.4 | 7.64 |
Additional Paid-In Capital | 6.02 | 6.02 | 6.02 | 6.02 | 4.49 |
Retained Earnings | -14.68 | -13.52 | -11.9 | -10.27 | -8.47 |
Total Common Equity | 1.53 | 1.75 | 3.37 | 4.15 | 3.67 |
Minority Interest | 0.07 | 0.04 | 0.08 | 0.1 | 0.11 |
Shareholders' Equity | 1.6 | 1.79 | 3.45 | 4.25 | 3.77 |
Total Liabilities & Equity | 4.66 | 3.95 | 5.26 | 6.22 | 5.21 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.86 | 0.43 | 0.42 | 0.42 | 0.46 |
Net Cash (Debt) | -0.16 | -0.13 | 0.91 | 1.19 | 1.51 |
Net Cash Growth | - | - | -23.39% | -21.26% | 352.90% |
Net Cash Per Share | -0.08 | -0.07 | 0.53 | 0.76 | 0.97 |
Filing Date Shares Outstanding | 2.04 | 1.85 | 1.85 | 1.68 | 1.53 |
Total Common Shares Outstanding | 2.04 | 1.85 | 1.85 | 1.68 | 1.53 |
Working Capital | 1.28 | 0.73 | 1.73 | 2.41 | 2.17 |
Book Value Per Share | 0.75 | 0.95 | 1.82 | 2.47 | 2.40 |
Tangible Book Value | 0.3 | 0.75 | 2.22 | 2.93 | 2.5 |
Tangible Book Value Per Share | 0.15 | 0.40 | 1.20 | 1.74 | 1.64 |
Land | 0.08 | 0.08 | 0.08 | 0.08 | 0 |
Machinery | 3.6 | 3.56 | 3.52 | 3.44 | 3.09 |